Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category
Biochemistry 40:1413442, PMID: 11714266 Reynaert NL, van der Vliet A, Guala AS, McGovern T, Hristova M, Pantano C, Heintz NH, Heim J, Ho YS, Matthews DE, Wouters EF, JanssenHeininger YM (2006) Dynamic redox control of NF-kappaB through glutaredoxin-regulated S -glutathionylation of inhibitory kappaB kinase beta
Connect with our health experts and get free assistance.
This study over a rather short period of time, 36 weeks, showed a weight reduction of 10.5%
Caught in the cROSsfire: GSH controls T cell metabolic reprogramming
These agents act on pathways of the brain that regulate weight and food intake, and when these patients are no longer receiving treatment, they no longer have these brain pathways to regulate weight, and they regain it, she says